Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data Vera Bradley, Inc. files with the SEC in its annual reports.
In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.
Income statement
FY2017
FY2018
FY2019
FY2020
FY2021
FY2022
FY2023
FY2024
FY2025
FY2026
Revenue
486
455
416
495
468
540
500
384
319
270
Cost of revenue
210
201
178
223
203
253
261
180
160
145
Gross profit
276
254
239
272
266
288
239
204
159
125
Selling, general and administrative
249
240
212
253
253
262
265
193
188
158
Operating income
28.2
15
27.1
19.5
13.1
26.9
-94.9
11.6
-28.8
-31.9
Interest expense
0.18
Pre-tax income
28
15.4
28.2
20.6
11.9
26.6
-95
12.3
-28
-32.4
Income tax
8.28
8.38
7.47
5.32
1.17
6.43
-15.6
3.68
5.34
0.3
Income from continuing operations
19.8
Net income
19.8
7.02
20.8
16
8.68
17.8
-59.7
7.84
-62.2
-47.8
EBITDA
47.7
34.6
43.6
37.9
26.5
36.2
-86
19.6
-20.3
-24.1
EPS, basic
0.54
0.20
0.59
0.47
0.26
0.53
-1.90
0.25
-2.15
-1.71
EPS, diluted
0.53
0.19
0.59
0.47
0.26
0.52
-1.90
0.25
-2.15
-1.71
Shares, basic (weighted)
36.8
35.9
35.2
34
33.4
33.8
31.5
30.8
28.9
27.9
Shares, diluted (weighted)
37
36
35.5
34.3
33.9
34.4
31.5
31.3
28.9
27.9
Balance sheet
FY2017
FY2018
FY2019
FY2020
FY2021
FY2022
FY2023
FY2024
FY2025
FY2026
Cash and equivalents
86.4
68.8
113
49.9
64.2
88.4
46.6
77.3
28.6
18.5
Short-term investments
30.2
54.2
19.4
8.98
1.3
0
Receivables
23.3
15.6
15.6
24.3
27.5
20.7
22.1
17.1
13.8
17.3
Inventory
102
87.8
91.6
124
141
145
142
118
91.4
76
Other current assets
10.2
11.3
11.6
11
17.9
15.9
14.3
12.8
8.07
6.03
Total current assets
256
242
252
219
260
279
227
226
165
120
Property, plant and equipment
102
86.5
78
73
64
59.9
58.7
54.3
52.6
46.4
Lease right-of-use assets
115
88.7
79.9
78
66.5
74.8
63.2
Goodwill
0
44.3
44.3
44.3
0
Intangible assets
0
56.3
47.3
44.2
15.9
7.57
0
Long-term investments
0
15.5
23.7
14.9
0
Other non-current assets
2.82
1.28
1.27
5.33
6.34
6.08
3.85
6.16
9.05
4.46
Total assets
374
351
362
535
514
518
405
381
307
234
Accounts payable
32.6
13.5
14.6
20.2
27.1
30.5
20.4
14.2
17.2
16.2
Accrued liabilities
12.5
13.6
13.3
11.4
13.6
12.5
14.3
12.9
6.53
5.39
Deferred revenue
1.6
3.9
4.1
3.9
3.2
2.6
1.7
1.6
Total current liabilities
62.5
40.3
43.6
87.4
77.4
78.1
67.7
58.3
58
50.5
Long-term debt
0
Lease liabilities
114
91.5
80.9
74.7
62.6
66.3
51.9
Other non-current liabilities
0.06
0.11
0.2
0.09
0.04
0.05
0
Total liabilities
89.7
65.4
67.4
201
169
159
142
121
128
102
Total debt
0
0
Paid-in capital
88.7
91.2
95.6
100
105
108
110
113
116
116
Retained earnings
264
271
292
307
317
334
275
282
220
172
Treasury stock
-68.7
-76.6
-92.8
-104
-107
-115
-133
-135
-157
-157
Other comprehensive income
-0.05
-0.11
-0.02
0.16
0.01
-0.03
-0.11
-0.07
-0.02
-0.13
Shareholders' equity
284
285
295
304
315
327
251
260
179
132
Total equity
284
285
295
304
315
327
251
260
179
132
Total liabilities and equity
374
351
362
535
514
518
405
381
307
234
Shares outstanding
36.2
35.5
34.3
33.5
33.4
33.2
30.8
30.8
27.7
28
Cash flow statement
FY2017
FY2018
FY2019
FY2020
FY2021
FY2022
FY2023
FY2024
FY2025
FY2026
Net income
19.8
7.02
20.8
15.2
10.7
20.2
-79.4
8.6
-33.4
-32.7
Depreciation and amortization
19.5
19.6
16.5
18.4
13.5
9.32
8.85
7.97
8.53
7.77
Stock-based compensation
4.03
3.07
4.93
5.94
5.65
4.93
3.24
2.94
3.68
0.87
Deferred income tax
-2.18
8.15
-1.5
-0.86
4.13
-0.33
-17.7
2.37
4.9
0
Change in receivables
7.54
7.32
0.44
-1.01
-5.58
6.76
-1.35
4.67
2.29
-4.34
Change in inventory
11.3
14.4
-3.99
-12.6
-17.8
-3.47
2.61
24
8.27
15.8
Change in payables
9
-18.2
0.74
-0.62
7.35
3.21
-10.2
-5.99
5.57
-2.12
Cash from operations
65.2
42.6
43.6
20.6
20.7
39.9
-13.4
48
-14.1
-9.97
Capital expenditures
-20.8
-11.8
-8.15
-13.3
-5.74
-5.49
-8.24
-3.77
-10.4
-3.29
Acquisitions
0
0
-76
0.99
0
0
-10
0
0
Purchases of investments
-30
-85.5
-59.5
-19
-0.85
0
0
Sales and maturities of investments
0
45.7
85.6
38.3
23.3
1.29
0
0
Cash from investing
-50.8
-51.6
18
-70
17.7
-4.15
-8.24
-13.8
-10.4
-1.54
Share buybacks
-25
-7.91
-16.1
-11.3
-3.08
-7.74
-18.1
-2.19
-21.8
0
Cash from financing
-25.7
-8.65
-16.8
-14.3
-24.1
-11.4
-20.1
-3.55
-22.5
-0.23
Exchange rate effect
-0.01
-0.01
-0.01
0.05
0.02
-0.03
-0.08
0.03
0.05
-0.11
Net change in cash
-11.3
-17.6
44.7
-63.6
14.3
24.3
-41.8
30.7
-46.9
-11.9
Free cash flow
44.4
30.8
35.4
7.31
15
34.4
-21.7
44.2
-24.5
-13.3
Interest paid
0.25
0.19
0.17
0.12
1.13
0.29
0.09
0.15
0.14
0.36
Income taxes paid
24.8
1.94
4.04
6.49
5.08
9.08
-6.57
0.84
1.35
0.07
Key metrics
Worked out from the statements above. Latest values use the trailing twelve months to August 1, 2026; growth uses fiscal years. Valuation uses the share price of $4.03 on September 25, 2026.
Profitability
Metric
Value
How it is calculated
Gross margin
50.4%
Gross profit / revenue.
Operating margin
-3.6%
Operating income / revenue.
EBITDA margin
-1.0%
EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin
-3.7%
Pre-tax income / revenue.
Net margin
-3.7%
Net income / revenue.
FCF margin
10.7%
Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin
11.3%
Cash from operations / revenue.
Return on equity (ROE)
-7.6%
Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)
-4.2%
Net income / average total assets.
Return on invested capital (ROIC)
-8.0%
Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
SG&A / revenue
54.6%
Selling, general and administrative expense / revenue.
Stock-based pay / revenue
1.3%
Stock-based compensation (from the cash flow statement) / revenue.
Capex / revenue
0.6%
Capital expenditures / revenue.
D&A / revenue
2.6%
Depreciation and amortization / revenue.
Growth
Metric
Value
How it is calculated
Revenue growth, 1y
-15.4%
Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y
-18.6%
Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y
-10.5%
Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Gross profit growth, 1y
-21.3%
Gross profit vs the same period a year earlier. Only from a positive base.
Gross profit CAGR, 3y
-19.4%
Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Gross profit CAGR, 5y
-14.0%
Compound annual growth of gross profit over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Book value growth, 1y
-26.4%
Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y
-19.4%
Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value CAGR, 5y
-16.0%
Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Total assets growth, 1y
-23.7%
Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y
-16.7%
Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y
-14.6%
Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y
-3.6%
Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y
-4.0%
Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y
-3.8%
Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.
Balance sheet health
Metric
Value
How it is calculated
Current ratio
2.44x
Current assets / current liabilities.
Quick ratio
0.91x
(Cash + short-term investments + receivables) / current liabilities.
Cash ratio
0.66x
(Cash + short-term investments) / current liabilities.
Days inventory + days sales outstanding - days payables.
Capex / operating cash flow
5.5%
Capital expenditures / cash from operations, when that is positive.
Per share
Metric
Value
How it is calculated
EPS, diluted
-$0.37
Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share
$9.15
Revenue / diluted weighted shares.
FCF per share
$0.98
Free cash flow / diluted weighted shares.
Operating cash flow per share
$1.03
Cash from operations / diluted weighted shares.
Book value per share
$4.61
Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Market cap + total debt - cash - short-term investments.
P/S
0.42x
Market cap / revenue.
P/B
0.87x
Market cap / shareholders' equity. Only when equity is positive.
Price / tangible book
0.87x
Market cap / tangible book value, when positive.
P/FCF
3.90x
Market cap / free cash flow. Only when free cash flow is positive.
P/OCF
3.69x
Market cap / cash from operations, when positive.
EV/Sales
0.29x
Enterprise value / revenue.
EV/FCF
2.73x
Enterprise value / free cash flow, when both are positive.
FCF yield
25.6%
Free cash flow / market cap.
Earnings yield
-8.8%
Net income / market cap (the inverse of P/E).
What was Vera Bradley, Inc.'s revenue in fiscal 2026?
Vera Bradley, Inc. reported revenue of $269.7M for fiscal 2026, 15.4% lower than the year before.
Was Vera Bradley, Inc. profitable in fiscal 2026?
No. It reported a net loss of $47.8M.
How much free cash flow did Vera Bradley, Inc. generate in fiscal 2026?
Cash from operations of $10.0M minus capital expenditures of $3.3M left free cash flow of -$13.3M.
Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.